dihydrolipoic acid has been researched along with Leucocythaemia in 1 studies
dihydrolipoic acid: RN given refers to parent cpd without isomeric designation
dihydrolipoic acid : A thio-fatty acid that is reduced form of lipoic acid. A potent antioxidant shown to directly destroy superoxide, hydroperoxy and hydroxyl radicals; also has neuroprotective and anti-tumour effects.
dihydrolipoate : The conjugate base of dihydrolipoic acid.
Excerpt | Relevance | Reference |
---|---|---|
"Etoposide (VP-16) is an antitumor drug currently in use for the treatment of a number of human cancers." | 1.29 | Tyrosinase-induced phenoxyl radicals of etoposide (VP-16): interaction with reductants in model systems, K562 leukemic cell and nuclear homogenates. ( Gantchev, T; Kagan, V; Stoyanovsky, D; Yalowich, J, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Stoyanovsky, D | 1 |
Yalowich, J | 1 |
Gantchev, T | 1 |
Kagan, V | 1 |
1 other study available for dihydrolipoic acid and Leucocythaemia
Article | Year |
---|---|
Tyrosinase-induced phenoxyl radicals of etoposide (VP-16): interaction with reductants in model systems, K562 leukemic cell and nuclear homogenates.
Topics: Ascorbic Acid; Cell Nucleus; Chromatography, High Pressure Liquid; Deferoxamine; Electron Spin Reson | 1993 |